ATU has become the first university in Ireland to introduce EpiPens as part of a new pilot scheme. The initiative, launched at ATU’s Killybegs campus, aims to improve emergency response for students with severe allergies. EpiPens are auto-injectors used to treat anaphylaxis, a life-threatening allergic reaction. The university has partnered with local health services to ensure proper training and availability.
The pilot program follows growing awareness of allergic conditions among students. ATU’s decision reflects a broader trend in educational institutions to prioritize health and safety measures. Officials say the program will be evaluated before potential expansion to other campuses.
Health experts note that early access to EpiPens can be critical in emergencies. The initiative also includes educational sessions for students and staff on recognizing and responding to allergic reactions. No immediate incidents have been reported since the program’s start.
The move has been welcomed by student representatives, who highlight the importance of proactive health policies. ATU remains the only institution in Ireland to implement this measure so far.
